The inflammatory bowel diseases (IBDs) are a group of heterogeneous disorders characterized by acute and chronic inflammatory changes in the small or large bowel, or in both. Increasing incidence and prevalence figures for IBD both in the developed and developing world indicate that environmental fa
The role of self-efficacy in inflammatory bowel disease management: Preliminary validation of a disease-specific measure
β Scribed by Laurie Keefer; Jennifer L. Kiebles; Tiffany H. Taft
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 97 KB
- Volume
- 17
- Category
- Article
- ISSN
- 1078-0998
No coin nor oath required. For personal study only.
β¦ Synopsis
Background: Inflammatory bowel diseases (IBDs) require selfmanagement skills that may be influenced by self-efficacy (SE). Self-efficacy represents an individual's perception of his or her ability to organize and execute the behaviors necessary to manage disease. The goal of this study was to develop a valid and reliable measure of IBD-specific SE that can be used in clinical and research contexts.
Methods: One hundred and twenty-two adults with a verified IBD diagnosis participated in the study. Data were pooled from 2 sources: patients from an outpatient university gastroenterology clinic (n ΒΌ 42) and a sample of online respondents (n ΒΌ 80). All participants (N ΒΌ 122) completed the IBD Self-Efficacy Scale (IBD-SES) and the Inflammatory Bowel Disease Questionnaire. Additionally, online participants completed the Brief Symptom Inventory-18 and the Rosenberg Self-Esteem Scale, whereas those in the clinic sample completed the Perceived Health Competence Scale, the Perceived Stress Questionnaire, and the Short Form Version 2 Health Survey.
Results:
The IBD-SES was initially constructed to identify 4 distinct theoretical domains of self-efficacy: (1) managing stress and emotions, (2) managing medical care, (3) managing symptoms and disease, and (4) maintaining remission. The 29-item IBD-SES has high internal consistency (r ΒΌ 0.96), high test-retest reliability (r ΒΌ 0.90), and demonstrates strong construct and concurrent validity with established measures.
Conclusions:
The IBD-SES is a critical first step toward addressing an important psychological construct that could influence treatment outcomes in IBD.
π SIMILAR VOLUMES
Background: Some reports highlight the potential application of fecal calprotectin as a direct biomarker of intestinal inflammation and, therefore, as support in choosing candidates for endoscopy. The value of 100 lg/g was recently assumed as the best cutoff for this assay. The purpose of this study
Studies on angiogenesis and lymphangiogenesis have gained special relevance in research into factors potentially influencing the pathogenesis and course of inflammatory bowel disease (IBD). The results of the few existing studies on the distribution and density of lymphatic vessels and blood vessels